1 / 68

Epidemiologic Research Designs

Epidemiologic Research Designs. Ramon Jason M. Javier, M.D., D.P.A.F.P. Department of Preventive and Community Medicine College of Medicine U.E.R.M.M.M.C.I. Objectives. To define epidemiology and differentiate the two main categories of epidemiologic work.

ely
Télécharger la présentation

Epidemiologic Research Designs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epidemiologic Research Designs Ramon Jason M. Javier, M.D., D.P.A.F.P. Department of Preventive and Community Medicine College of Medicine U.E.R.M.M.M.C.I.

  2. Objectives • To define epidemiology and differentiate the two main categories of epidemiologic work. • To review the various epidemiologic studies, as well as the different research designs used in Medicine

  3. Epidemiology Epidemiology is the study of the distribution and determinants of disease in human population. Epidemiology has two main categories of work: • Descriptive Epidemiology • Analytic Epidemiology

  4. Descriptive Epidemiology Descriptive Epidemiology includes activities related to characterizing the distribution of diseases within a population.

  5. Descriptive Epidemiology • Community Reaction to Disease • absence of disease • sporadic occurrence • endemic occurrence • epidemic

  6. Descriptive Epidemiology • Descriptive Variables • time / temporal variation • place • person

  7. Analytic Epidemiology Analytic Epidemiology is concerned with activities related to identifying possible causes for the occurrence of diseases. It essentially identifies determinantsof disease occurrence.

  8. Applications of Epidemiology • disease surveillance • searching for causes of disease • diagnostic testing • determining natural history of disease • searching for prognostic factors • testing new treatments • evaluating community health interventions

  9. Epidemiologic Research Designs • Observational Designs • Experimental Designs

  10. Observational Designs • Descriptive Study • Case Report • Case Series • Cross-Sectional* (Survey Studies) • Analytic Study • Cross-Sectional* • Cohort Study • Case-Control Study

  11. Experimental Designs Analytic Study • Clinical Trial • Randomized Clinical Trial • Quasi-Experimental • Field Trial

  12. Case Report A case report is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. A case report may contain the demographic profile of an individual patient, that usually describes an unusual or novel occurrence.

  13. Case Report Most case reports focus on: • an unexpected association between diseases or symptoms • an unexpected event in the course of observing or treating a patient • findings that shed new light on the possible pathogenesis of a disease or an adverse effect

  14. Case Report Most case reports focus on: (continued) • unique or rare features of a disease • unique therapeutic approaches • a positional or quantitative variation of the anatomical structures

  15. Case Series A case series is a medical research study very similar in structure and form as case reports, but describes a group of cases, instead of a single patient. This study design may be retrospective or prospective, and usually requires a relatively small sample size (usually 10 or more).

  16. Case Series This design reports the frequency of events or outcomes of a disease, but does not show temporal relationships between events and outcomes. This study design has case selection bias and lacks statistical validity.

  17. Cross-Sectional Study In a cross-sectional study, the variables are all measured at a single point in time, with no structural distinction between predictors (exposure) and outcomes. It may involve the measurement of current exposure and/or historic exposure.

  18. Cross-Sectional Study This design is valuable for providing descriptive information about prevalence --- it is well suited to the goal of describing variables and their distribution patterns.

  19. Cross-Sectional Study This design may also be used for examining associations, although the choice of which variables to label as predictors and which as outcomes depends on the cause-and-effect hypotheses of the investigators.

  20. Cross-Sectional Study

  21. Cross-Sectional Study Uses for Cross-Sectional Study: • to assess burden of disease in a population and to assess need for health services • to compare prevalence of disease in different populations • to examine trends in disease prevalence or severity over time

  22. Cross-Sectional Study Strengths of Cross-Sectional Study: • allows study of several outcomes simultaneously • requires a relatively short duration • yields prevalence

  23. Cross-Sectional Study Weaknesses of Cross-Sectional Study: • does not establish sequence of events (temporality) • need for a large sample size • not feasible for rare predictors or rare outcomes • does not yield incidence or true relative risk

  24. Cohort Study Cohort studies involve following groups of subjects over time. There are two primary purposes: • descriptive: typically describes the incidence of certain outcomes over time • analytic: analyze associations between predictors (exposure) and outcomes

  25. Cohort Study Cohort studies establish sequence of events and can study several outcomes. This study yields incidence and relative risk.

  26. Cohort Study There are two sub-types: • Concurrent / Prospective • follows up cohorts from exposure to the occurrence of the effect • Non-Concurrent / Retrospective • both exposure and effect have occurred prior to the time of investigation

  27. Cohort Study: Prospective

  28. Cohort Study: Retrospective

  29. Cohort Study

  30. Cohort Study Incidence Rates: • exposed: IRexposed = A ÷ (A + B) • unexposed: IRunexposed = C ÷ (C + D) Relative Risk (RR): • RR = (IRexposed) ÷ (IRunexposed) • RR = [A ÷ (A + B)] ÷ [C ÷ (C + D)]

  31. Cohort Study Strengths of Cohort Study: • establishes sequence of events (temporality) • can study several outcomes • yields incidence, relative risk • prospective cohort studies avoid bias in measuring predictors • retrospective cohort studies are less expensive and have shorter duration

  32. Cohort Study Weaknesses of Cohort Study: • often requires a large sample size • less feasible for rare outcomes • prospective cohort studies are more expensive and longer in duration • retrospective cohort studies have less control over selection of subjects and measurements

  33. Case-Control Study A case-control study is a design in which individuals with an event or condition of interest (i.e. cases) are identified and then compared with regard to one or more exposures to individuals without the event or condition of interest (i.e. controls).

  34. Case-Control Study A case-control study cannot yield estimates of incidence or prevalence of a disease, but it can provide descriptive information on the characteristics of the cases and an estimate of the strength of association between predictor variables and the presence or absence of disease.

  35. Case-Control Study

  36. Case-Control Study Estimates of strength of association are in the form of odds ratio (OR). OR = (AD) ÷ (BC)

  37. Case-Control Study Interpretation of OR: • OR = 1: exposure is not related with disease • OR > 1: exposure is positively related with disease • OR < 1: exposure is negatively related with disease

  38. Case-Control Study Exposure is determined in a retrospective manner; thus, one must look back in time to assess exposure status before a person developed the disease (and became a “case”). Ideally, exposure must be measured in a blinded manner,, to minimize bias.

  39. Case-Control Study

  40. Case-Control Study Types of Bias: • Selection Bias • This represents a distortion in the relationship between exposure and outcome, that results from selection of study participants.

  41. Case-Control Study Types of Bias: A. Selection Bias • The relation between exposure and outcome is different for those who participate and those who do not participate but would theoretically be eligible for the study.

  42. Case-Control Study • Information Bias • This is a distortion in measuring exposure or outcome data that results in different quality (i.e., accuracy or reliability) or frequency of information between comparison groups.

  43. Case-Control Study C. Recall Bias • Differential recall of exposure between cases and controls in a study may be evident.

  44. Case-Control Study Strengths of Case-Control Study: • useful for studying rare conditions • short duration • generally inexpensive • relatively small • yields odds ratio

  45. Case-Control Study Weaknesses of Case-Control Study: • potential for bias and confounding from sampling two populations • does not establish sequence of events • limited to one outcome • does not yield prevalence or incidence

  46. Clinical Trial In clinical trials, the investigator applies a treatment (termed intervention) and observes the effect on an outcome. Clinical trials are essentially cohort studies, except that the groups being studied differ from each other only in the presence of a characteristic or exposure to some factor that is artificially induced.

  47. Clinical Trial The major advantage of a trial over an observational study is the ability to demonstrate causality. Clinical trials are considered as the gold standard for studying interventions, specifically, randomized clinical trials. In clinical trials, biases are minimized but not totally eliminated.

  48. Clinical Trial In particular, randomly assigning the intervention can eliminate the influence of confounding variables. Blinding eliminates the possibility that the observed effects of the intervention are due to other treatments or to biased ascertainment.

  49. Clinical Trial Randomization: • intervention group – which will receive the experimental treatment • control group – which will receive the non-experimental treatment, either placebo or standard method of treatment

  50. Clinical Trial

More Related